Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
✉ Email this page to a colleague
MITSUBISHI TANABE PHARMA CORPORATION v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-07-13 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 7,943,582; 8,513,202 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in MITSUBISHI TANABE PHARMA CORPORATION v. PRINSTON PHARMACEUTICAL, INC.
Details for MITSUBISHI TANABE PHARMA CORPORATION v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
0000-00-00 | 24 | United States Patent Nos. 7,943,582 (the “’582 patent”) and 8,513,202 (the “’202 patent”) (collectively…infringement of U.S. Patent Nos. 7,943,582 (“the ’582 Patent”) and 8,513,202 (“the ’202 Patent”) (collectively… Alleged Infringement of U.S. Patent No. 7,943,582 by Hetero 114. Plaintiffs …collectively, the “Patents-in-suit”) under the patent laws of the United States, 35 U.S.C. §100, et seq. This…collectively the “patents- in-suit”) under the patent laws of the United States, 35 U.S.C. §§ 100 et seq. Hetero | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |